nadolol
Selected indexed studies
- Clinical pharmacokinetics of nadolol: A systematic review. (J Clin Pharm Ther, 2022) [PMID:36040016]
- Nadolol: a new beta-adrenoceptor antagonist. (N Engl J Med, 1981) [PMID:6115316]
- Green tea and nadolol interaction: A risk of therapeutic inefficiency, a case report and extensive review. (Therapie, 2024) [PMID:37951784]
_Worker-drafted node — pending editorial review._
Connections
nadolol is a side effect of
Sources
- Clinical pharmacokinetics of nadolol: A systematic review. (2022) pubmed
- Nadolol: a new beta-adrenoceptor antagonist. (1981) pubmed
- Green tea and nadolol interaction: A risk of therapeutic inefficiency, a case report and extensive review. (2024) pubmed
- Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. (1980) pubmed
- Nadolol in thyrotoxicosis. (1982) pubmed
- Propranolol versus nadolol for treatment of pediatric subglottic hemangioma. (2021) pubmed
- Dose response to nadolol in congenital long QT syndrome. (2021) pubmed
- Primary prophylaxis of variceal bleeding. (2018) pubmed
- Nadolol (Corgard). (1983) pubmed
- Nadolol-induced painful gingival bleeding. (2002) pubmed